Funding for this research was provided by:
National Institute of General Medical Sciences (GM092821-02)
Received: 13 June 2018
Accepted: 22 August 2018
First Online: 14 September 2018
: This project was conducted under Protocol #19753 which was approved by the Institutional Animal Care and Use Committee of the University of California, Davis.
: Not applicable.
: Aspects of this work are included in intellectual property filings and issued patents regarding the identification and use of new inhalation anesthetics and analgesics. Dr. Brosnan is the inventor of record, and patents are owned by the University of California. The University of California has licensed this intellectual property to Expanesthetics, Inc. (Davis, CA), and Dr. Brosnan is Chair of the Expanesthetics Scientific Advisory Board. Neither Dr. Brosnan nor Mr. Pham has received financial compensation from Expanesthetics, Inc., and neither owns equity in Expanesthetics, Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.